FDA Approved: UPLIZNA — Original Application (Horizon Therapeutics USA, Inc.)

View source ↗

Summary

FDA approved UPLIZNA (inebilizumab) in an original application for the treatment of neuromyelitis optica spectrum disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• Uplizna (inebilizumab)

Snippet

ORIG AP for UPLIZNA (INEBILIZUMAB)